NewsEvents

Your Yourlocation: Home > Efficacy of salmeterol combined with tiotropium bromide(136310-93-5) in the treatment of severe chronic obstructive pulmonary disease

The study of the combined inhaled salmeterol and tiotropium bromide(136310-93-5) in the treatment of severe COPD remission period observation, the study found that combined with salmeterol and tiotropium inhalation of tretinoin in the treatment of severe chronic obstructive pulmonary disease Remission of a significant effect, no serious adverse reactions. The article published in 2014 04 of "Chinese Pharmacoeconomics" on.

The aim of this study was to evaluate the efficacy of combined inhaled salmeterol and tiotropium bromide(136310-93-5) in the treatment of patients with severe chronic obstructive pulmonary disease (COPD) remission.

METHODS: Sixty patients with severe COPD remission were randomly assigned to receive salmeterol, tiotropium bromide(136310-93-5), and tiotropium plus tiotropium, respectively. Treatment for 6 months. The pulmonary function, blood gas analysis and adverse reactions were recorded before and after treatment.

The results showed that lung function improved in all three groups of patients with COPD, and salmeterol and tiotropium were more effective than salmeterol alone or tiotropium alone (P <0.05), and no serious adverse reactions.

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved